60 CD8+ T cells in the murine renal cancer Renca: cytotoxic activity and anti-tumor effects in vivo
Seki N1, Brooks AD2, Mason AT1, Wine JW1, Back TC2, Parsoneault EM2, Wiltrout RH1, and Sayers TJ21Laboratory of Experimental Immunology, CCR, NCI-Frederick, 2SAIC-Frederick, Frederick, MD
61 Assessment of Stability of Expression of Tumor-Associated Antigens in an Allogeneic Ovarian Cancer Cell Vaccine
Selvan RS1, Malone CC1, Bauer JA1, Brown BW1, Ravi S1, Spencer KS1, Chen Y2, Dan Q2, Jadus MR2, Lebeck LK3, Heinemann FS1, Dillman RO11Hoag Cancer Center, Newport Beach; 2VA Administration, Long Beach; 3University of California, San Diego, CA
62 IFN-γ responsiveness of mouse renal cell carcinoma cells contributes to host-mediated antimetastatic effects
Lynnette H. Shorts1, M. Eilene Gruys1, Timothy C. Back2, Jon M. Wigginton3, Jeff Subleski1, Robert H. Wiltrout11NCI-CCR and 2SAIC Frederick, Frederick, MD 3POB, Bethesda, MD
63 FLT3 Ligand: A Potential New Immunorestorative Agent?
Sinha, Manoj; Fry, Terry; Mackall, Crystal L.
Pediatric Oncology, NCI, NIH, Bethesda, MD
64 Induction of MIG and IP-10 gene expression by LPS and IL-12/pulse IL-2 in kidney messangial cells can use IFN-γ dependent and independent pathways
Jeff Subleski1, Jong-Wook Park2, Chris Wallace1, Jon Wigginton3 and Robert H. Wiltrout11Experimental Therapeutics Section, Laboratory of Experimental Immunology, Division of Basic Sciences, NCI-FCRDC, Frederick, MD; 2Institute for Medical Sciences of Keimyung University, Taegu Korea; 3Division of Basic Sciences and Pediatric Oncology Branch, Division of Clinical Sciences, NIH, Bethesda, MD
65 Immunologic and Hematopoietic Effects of Recombinant Human Prolactin After Syngeneic Bone Marrow Transplantation in Mice
Sun, Rui; Welniak, Lisbeth; Tian, Zhigang; Murphy, William J.
LMI, NCI at Frederick Frederick, MD
66 Tumors induce apoptosis in T cells by both caspase-8 dependent receptor mediated apoptosis and caspase-8 independent pathways
Charlie Tannenbaum, Patricia Rayman, Luis Molto, Ronald Bukowski and James Finke
Cleveland Clinic Foundation
67 Dendritic Cell Expression of a Modified Vaccinia Ankara Virus Encoding MUC1 and IL-2
Trevor KT1, Hersh EM1, Brailey J1, Balloul J-M2, Acres B21Arizona Cancer Center, Tucson, AZ; 2Transgene SA, Strasbourg, France
68 Membrane Expression of Macrophage Colony Stimulating Factor (mM-CSF) on MADB106 Breast Cancer Cells is Not Associated with In Vitro Cytotoxicity by Macrophages But is Associated with the Induction Lasting Tumor Immunity Against Syngeneic Breast Cancer Cells In Vivo
Trinh H, Tran TV, Williams CC, Dan Q, Sanchez R, Delgado C, Chen Y, Sippel B, Jeffes EWB, Wepsic HT, Jadus MR
Departments of Laboratory Service and Dermatology Service, Veterans Affairs Medical Center, Long Beach CA and The University of California, Irvine, CA
69 Preferential apoptosis of the CD8+CD28- T cell subset of effector cells in the peripheral blood of patients with head and neck cancer
Takashi Tsukishiro, Albert Donneberg and Theresa L. Whiteside
University of Pittsburgh Cancer Institute, Pittsburgh, PA
70 Real-time polymerase chain reaction monitoring of Ep-CAM-induced T cell stimulation in lung cancer patients and healthy individuals using the LightCycler™ technology
Urosevic M2, Nestle FO2, Dummer R2, Stahel RA1, Trojan A11Division of Oncology, Department of Internal Medicine; 2Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
71 Can imiquimod awake basal cell carcinomas from immunological dormancy? – gene expression profiling of basal cell carcinomas treated with imiquimod
Urosevic M, Willers J, Keist R*, Huopanemi L*, Rudolph U*, Burg G, Dummer R
Department of Dermatology, University Hospital Zurich, *Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland